Log in

Galectin Therapeutics SEC Filings & 10K Form (NASDAQ:GALT)

$1.92
-0.19 (-9.00 %)
(As of 03/29/2020 03:10 PM ET)
Today's Range
$1.91
Now: $1.92
$2.06
50-Day Range
$1.51
MA: $2.24
$2.84
52-Week Range
$1.50
Now: $1.92
$5.19
Volume164,603 shs
Average Volume280,891 shs
Market Capitalization$109.50 million
P/E RatioN/A
Dividend YieldN/A
Beta2.93

SEC Filings

Galectin Therapeutics (NASDAQ:GALT) SEC Filings

DateFilerForm TypeView
03/20/2020
7:30 AM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
7:01 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2020
6:57 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2020
6:52 AM
Galectin Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2020
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
3:54 PM
10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:09 PM
Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:05 PM
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:05 PM
ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:05 PM
AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:02 PM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:02 PM
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:01 PM
Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
4:58 PM
CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
4:56 PM
Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
4:55 PM
Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
8:01 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2019
8:26 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2019
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2019
9:01 AM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
6:54 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
6:52 AM
Galectin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2019
7:00 AM
Galectin Therapeutics (Filer)
Form DEF 14A
10/15/2019
5:56 AM
10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
7:30 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
6:50 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
2:00 PM
AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
12:30 PM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
11:15 PM
Galectin Therapeutics (Filer)
Form EFFECT
08/09/2019
3:32 PM
Galectin Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/09/2019
6:59 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
6:53 AM
Galectin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2019
7:00 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2019
5:03 AM
10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
12:13 PM
10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
5:10 PM
Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
Form 4/A
06/03/2019
4:45 PM
CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:42 PM
ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:31 PM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:29 PM
Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:29 PM
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
4:28 PM
Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2019
7:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
7:02 AM
Galectin Therapeutics (Subject)
Form FWP
05/10/2019
6:59 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
6:56 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2019
6:52 AM
Galectin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2019
2:13 PM
Galectin Therapeutics (Filer)
Form 424B1
04/15/2019
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2019
11:16 PM
Galectin Therapeutics (Filer)
Form EFFECT
04/12/2019
8:01 AM
Galectin Therapeutics (Filer)
Form S-3/A
04/09/2019
3:02 PM
Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
3:46 PM
Galectin Therapeutics (Filer)
Form S-3/A
04/08/2019
3:32 PM
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
3:31 PM
Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
3:30 PM
Galectin Therapeutics (Subject)
Uihlein Richard E (Filed by)
Form SC 13D/A
04/08/2019
3:30 PM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
7:45 AM
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
04/01/2019
5:02 PM
10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
04/01/2019
4:59 PM
10X Capital Management, LLC (Reporting)
10X Fund, L.P. (Reporting)
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2019
3:37 PM
10X Fund, L.P. (Filed by)
Galectin Therapeutics (Subject)
Form SC 13D/A
03/21/2019
4:00 PM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2019
4:17 PM
Galectin Therapeutics (Filer)
Form S-3/A
03/06/2019
6:58 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
6:53 AM
Galectin Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/06/2019
6:53 AM
Galectin Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2019
3:38 PM
Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2019
3:30 PM
AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2019
9:55 AM
Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
Form 4/A
01/30/2019
4:31 PM
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
4:31 PM
Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
5:23 PM
AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
3:31 PM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2019
4:20 PM
Galectin Therapeutics (Issuer)
Uihlein Richard E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:20 PM
Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:20 PM
ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:19 PM
CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:19 PM
Galectin Therapeutics (Issuer)
SHULMAN STEPHEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:18 PM
Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:18 PM
FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:17 PM
AMELIO GILBERT F (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:17 PM
Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:16 PM
CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2019
4:16 PM
Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2019
7:30 AM
Galectin Therapeutics (Filer)
Form 8-K/A
12/20/2018
7:25 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
6:55 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
6:51 AM
Galectin Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/28/2018
3:32 PM
Galectin Therapeutics (Filer)
Form 10-Q/A
09/28/2018
3:31 PM
Galectin Therapeutics (Filer)
Form 10-K/A
09/26/2018
6:59 AM
ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
11:28 AM
Galectin Therapeutics (Filer)
Form 424B3
09/20/2018
6:51 AM
Galectin Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2018
3:06 PM
Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2018
11:15 PM
Galectin Therapeutics (Filer)
Form EFFECT
09/06/2018
3:24 PM
Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
3:08 PM
Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 3/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel